⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 1, 1984Drug Metabolism Reviews

The QSAR Paradigm in the Design of Less Toxic Molecules

View at Publisher

Ask AI

Bookmark

Share

Abstract

(1984). The QSAR Paradigm in the Design of Less Toxic Molecules. Drug Metabolism Reviews: Vol. 15, No. 7, pp. 1279-1294.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Corwin Hansch (1984) studied this question.

synapsesocial.com/papers/6a765a979d809400dabd25f6 https://doi.org/10.3109/03602538409029960

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A New Substituent Constant, π, Derived from Partition CoefficientsOriginal Research · 1964 · 1,371 citations
2Ames test of 1-(X-phenyl)-3,3-dialkyltriazenes. A quantitative structure-activity studyIn Vitro Study · 1979 · 49 citations
3Theoretical and experimental relationships between soil adsorption, octanol-water partition coefficients, water solubilities, bioconcentration factors, and the parachorOriginal Research · 1981 · 561 citations
4Partition equilibriums of nonionic organic compounds between soil organic matter and waterOriginal Research · 1983 · 971 citations
5Partition coefficient to measure bioconcentration potential of organic chemicals in fishOriginal Research · 1974 · 650 citations

More related papers

Measuring and Estimating the Bioconcentration Factor of Chemicals in Fish1979
Quantitative structure-activity relationships in 1-aryl-2-(alkylamino)ethanol antimalarials1979
Potential antitumor agents. 36. Quantitative relationships between experimental antitumor activity, toxicity, and structure for the general class of 9-anilinoacridine antitumor agents1982

More from Drug Metabolism Reviews

Schisandrol A and Schisandrol B from Schisandra chinensis : Drug Metabolism, Transporter Interactions, and Herb–Drug Interaction PotentialWed,
Rare Mendelian CYP Disorders: From Metabolic Pathways to Biomarker-Guided DiagnosisMon,